MARC D KOZIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARC D KOZIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARC D KOZIN. MARC D KOZIN is Director in Solexa, Inc. ($LYNX) and Director in UFP TECHNOLOGIES INC ($UFPT) and in DYAX CORP ($DYAX) and Director in DYAX CORP ($DYAX) and Director in ENDOCYTE INC ($ECYT) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in OvaScience, Inc. ($OVAS) and Director in Flex Pharma, Inc. ($FLKS).
Latest Insider Trading Transactions of MARC D KOZIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DRNA, DYAX, ECYT, OVAS, FLKS, LYNX, UFPT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 10 2021 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Gift | G | 0.00 | 4,000 | 0 | 27,400 | 31.4 K to 27.4 K (-12.74 %) |
Mar 10 2021 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 54.97 | 600 | 32,982 | 31,400 | 32 K to 31.4 K (-1.87 %) |
Mar 10 2021 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 54.35 | 8,466 | 460,127 | 32,000 | 40.5 K to 32 K (-20.92 %) |
Mar 10 2021 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 52.59 | 200 | 10,518 | 40,466 | 40.7 K to 40.5 K (-0.49 %) |
Mar 10 2021 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 51.28 | 234 | 12,000 | 40,666 | 40.9 K to 40.7 K (-0.57 %) |
Mar 10 2021 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 50.66 | 500 | 25,330 | 40,900 | 41.4 K to 40.9 K (-1.21 %) |
Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | KOZIN MARC D | Director | Option Exercise | A | 21.61 | 15,000 | 324,150 | 15,000 | |
Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | KOZIN MARC D | Director | Option Exercise | A | 0.00 | 3,333 | 0 | 3,333 | |
Jun 12 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | A | 43.95 | 2,482 | 109,084 | 2,482 | |
Jun 12 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Grant | A | 0.00 | 796 | 0 | 41,400 | 40.6 K to 41.4 K (+1.96 %) |
Mar 11 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 47.47 | 1,000 | 47,470 | 40,604 | 41.6 K to 40.6 K (-2.40 %) |
Mar 11 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 46.21 | 1,133 | 52,356 | 41,604 | 42.7 K to 41.6 K (-2.65 %) |
Mar 11 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 45.55 | 2,600 | 118,430 | 42,737 | 45.3 K to 42.7 K (-5.73 %) |
Mar 11 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 44.84 | 200 | 8,968 | 45,337 | 45.5 K to 45.3 K (-0.44 %) |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 31.20 | 1,724 | 53,789 | 0 | |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 27.05 | 2,056 | 55,615 | 0 | |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 22.02 | 2,864 | 63,065 | 0 | |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 19.97 | 2,921 | 58,332 | 0 | |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 25.04 | 2,088 | 52,284 | 0 | |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 19.08 | 1,227 | 23,411 | 0 | |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 16.32 | 1,295 | 21,134 | 0 | |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 16.17 | 2,058 | 33,278 | 0 | |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 31.20 | 1,724 | 53,789 | 45,537 | 43.8 K to 45.5 K (+3.93 %) |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 27.05 | 2,056 | 55,615 | 43,813 | 41.8 K to 43.8 K (+4.92 %) |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 22.02 | 2,864 | 63,065 | 41,757 | 38.9 K to 41.8 K (+7.36 %) |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 19.97 | 2,921 | 58,332 | 38,893 | 36 K to 38.9 K (+8.12 %) |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 25.04 | 2,088 | 52,284 | 35,972 | 33.9 K to 36 K (+6.16 %) |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 19.08 | 1,227 | 23,411 | 33,884 | 32.7 K to 33.9 K (+3.76 %) |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 16.32 | 1,295 | 21,134 | 32,657 | 31.4 K to 32.7 K (+4.13 %) |
Mar 10 2020 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 16.17 | 2,058 | 33,278 | 31,362 | 29.3 K to 31.4 K (+7.02 %) |
Sep 12 2019 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 40.05 | 455 | 18,223 | 29,304 | 29.8 K to 29.3 K (-1.53 %) |
Sep 12 2019 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 39.90 | 3,342 | 133,346 | 29,759 | 33.1 K to 29.8 K (-10.10 %) |
Sep 12 2019 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 40.53 | 1,075 | 43,570 | 33,101 | 34.2 K to 33.1 K (-3.15 %) |
Sep 12 2019 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Sell | S | 39.50 | 1,535 | 60,633 | 34,176 | 35.7 K to 34.2 K (-4.30 %) |
Sep 09 2019 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 9.25 | 3,500 | 32,375 | 0 | |
Sep 09 2019 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 9.09 | 2,907 | 26,425 | 0 | |
Sep 09 2019 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 9.25 | 3,500 | 32,375 | 35,711 | 32.2 K to 35.7 K (+10.87 %) |
Sep 09 2019 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 9.09 | 2,907 | 26,425 | 32,211 | 29.3 K to 32.2 K (+9.92 %) |
Jun 21 2019 | DRNA | Dicerna Pharmaceut ... | KOZIN MARC D | Director | Option Exercise | A | 15.44 | 25,000 | 386,000 | 25,000 | |
Jun 21 2019 | DRNA | Dicerna Pharmaceut ... | KOZIN MARC D | Director | Option Exercise | A | 15.44 | 25,000 | 386,000 | 25,000 | |
Jun 07 2019 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | A | 38.61 | 2,756 | 106,409 | 2,756 | |
Jun 07 2019 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Grant | A | 0.00 | 907 | 0 | 29,304 | 28.4 K to 29.3 K (+3.19 %) |
Jan 25 2019 | DRNA | Dicerna Pharmaceut ... | KOZIN MARC D | Director | Option Exercise | A | 10.31 | 25,000 | 257,750 | 25,000 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | D | 10.81 | 19,500 | 210,795 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | D | 2.27 | 19,500 | 44,265 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | D | 3.35 | 13,500 | 45,225 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | D | 6.02 | 13,500 | 81,270 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | D | 6.69 | 14,000 | 93,660 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | D | 12.94 | 14,000 | 181,160 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | D | 7.71 | 20,000 | 154,200 | 0 | |
Dec 21 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Sell | D | 24.00 | 3,300 | 79,200 | 0 | 3.3 K to 0 (-100.00 %) |
Dec 21 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Sell | D | 24.00 | 7,800 | 187,200 | 0 | 7.8 K to 0 (-100.00 %) |
Dec 11 2018 | OVAS | Millendo Therapeut ... | KOZIN MARC D | Director | Grant | A | 0.00 | 831 | 0 | 7,740 | 6.9 K to 7.7 K (+12.03 %) |
Oct 02 2018 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 16,014 | 0 | 103,647 | 87.6 K to 103.6 K (+18.27 %) |
Jul 26 2018 | FLKS | Flex Pharma, Inc. | KOZIN MARC D | Director | Option Exercise | A | 0.82 | 10,000 | 8,200 | 10,000 | |
Jul 06 2018 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Option Exercise | A | 0.95 | 12,000 | 11,458 | 12,000 | |
Jul 06 2018 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Option Exercise | A | 0.95 | 12,000 | 11,458 | 12,000 | |
Jun 07 2018 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | A | 31.20 | 1,724 | 53,789 | 1,724 | |
Jun 07 2018 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Grant | A | 0.00 | 561 | 0 | 28,397 | 27.8 K to 28.4 K (+2.02 %) |
May 16 2018 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 10.14 | 4,500 | 45,630 | 0 | |
May 16 2018 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 12.37 | 2,615 | 32,348 | 0 | |
May 16 2018 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 10.14 | 4,500 | 45,630 | 27,836 | 23.3 K to 27.8 K (+19.28 %) |
May 16 2018 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 12.37 | 2,615 | 32,348 | 23,336 | 20.7 K to 23.3 K (+12.62 %) |
May 04 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | A | 10.81 | 19,500 | 210,795 | 19,500 | |
May 04 2018 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Grant | A | 0.00 | 3,300 | 0 | 11,100 | 7.8 K to 11.1 K (+42.31 %) |
Apr 03 2018 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 14,411 | 0 | 74,753 | 60.3 K to 74.8 K (+23.88 %) |
Jan 03 2018 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 8,348 | 0 | 60,342 | 52 K to 60.3 K (+16.06 %) |
Oct 03 2017 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 8,230 | 0 | 51,994 | 43.8 K to 52 K (+18.81 %) |
Jul 27 2017 | FLKS | Flex Pharma, Inc. | KOZIN MARC D | Director | Option Exercise | A | 4.08 | 12,000 | 48,960 | 12,000 | |
Jul 05 2017 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 6,477 | 0 | 43,764 | 37.3 K to 43.8 K (+17.37 %) |
Jun 23 2017 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Option Exercise | A | 1.46 | 12,000 | 17,520 | 12,000 | |
Jun 08 2017 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | A | 27.05 | 2,056 | 55,615 | 2,056 | |
Jun 08 2017 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Grant | A | 0.00 | 647 | 0 | 20,721 | 20.1 K to 20.7 K (+3.22 %) |
May 05 2017 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Grant | A | 0.00 | 3,300 | 0 | 7,800 | 4.5 K to 7.8 K (+73.33 %) |
Apr 04 2017 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 5,180 | 0 | 37,287 | 32.1 K to 37.3 K (+16.13 %) |
Jan 04 2017 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 1.53 | 6,331 | 9,686 | 32,107 | 25.8 K to 32.1 K (+24.56 %) |
Oct 04 2016 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 1,353 | 0 | 25,776 | 24.4 K to 25.8 K (+5.54 %) |
Jul 05 2016 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 1,859 | 0 | 24,423 | 22.6 K to 24.4 K (+8.24 %) |
Jun 13 2016 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | A | 22.02 | 2,864 | 63,065 | 2,864 | |
Jun 13 2016 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Grant | A | 0.00 | 794 | 0 | 20,074 | 19.3 K to 20.1 K (+4.12 %) |
Jun 09 2016 | FLKS | Flex Pharma, Inc. | KOZIN MARC D | Director | Option Exercise | A | 12.21 | 10,000 | 122,100 | 10,000 | |
Jun 06 2016 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Option Exercise | A | 7.38 | 12,000 | 88,560 | 12,000 | |
May 09 2016 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 5.19 | 4,500 | 23,355 | 0 | |
May 09 2016 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 5.06 | 4,390 | 22,213 | 0 | |
May 09 2016 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | M | 6.01 | 4,500 | 27,045 | 0 | |
May 09 2016 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 5.19 | 4,500 | 23,355 | 19,280 | 14.8 K to 19.3 K (+30.45 %) |
May 09 2016 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 5.06 | 4,390 | 22,213 | 14,780 | 10.4 K to 14.8 K (+42.25 %) |
May 09 2016 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Buy | M | 6.01 | 4,500 | 27,045 | 10,390 | 5.9 K to 10.4 K (+76.40 %) |
May 06 2016 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Grant | A | 0.00 | 2,250 | 0 | 4,500 | 2.3 K to 4.5 K (+100.00 %) |
Apr 04 2016 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 1,020 | 0 | 22,564 | 21.5 K to 22.6 K (+4.73 %) |
Jan 22 2016 | DYAX | DYAX CORP | KOZIN MARC D | Option Exercise | D | 26.23 | 8,333 | 218,575 | 0 | ||
Jan 22 2016 | DYAX | DYAX CORP | KOZIN MARC D | Option Exercise | D | 2.30 | 8,333 | 19,166 | 0 | ||
Jan 22 2016 | DYAX | DYAX CORP | KOZIN MARC D | Sell | D | 0.00 | 131,305 | 0 | 0 | 131.3 K to 0 (-100.00 %) | |
Jan 15 2016 | DYAX | DYAX CORP | KOZIN MARC D | Director | Option Exercise | M | 26.23 | 16,667 | 437,175 | 8,333 | |
Jan 15 2016 | DYAX | DYAX CORP | KOZIN MARC D | Director | Option Exercise | M | 2.30 | 66,667 | 153,334 | 8,333 | |
Jan 15 2016 | DYAX | DYAX CORP | KOZIN MARC D | Director | Option Exercise | M | 3.00 | 25,000 | 75,000 | 0 | |
Jan 15 2016 | DYAX | DYAX CORP | KOZIN MARC D | Director | Buy | M | 26.23 | 16,667 | 437,175 | 131,305 | 114.6 K to 131.3 K (+14.54 %) |
Jan 15 2016 | DYAX | DYAX CORP | KOZIN MARC D | Director | Buy | M | 2.30 | 66,667 | 153,334 | 114,638 | 48 K to 114.6 K (+138.97 %) |
Jan 15 2016 | DYAX | DYAX CORP | KOZIN MARC D | Director | Buy | M | 3.00 | 25,000 | 75,000 | 47,971 | 23 K to 48 K (+108.83 %) |
Jan 05 2016 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 991 | 0 | 21,544 | 20.6 K to 21.5 K (+4.82 %) |
Nov 23 2015 | FLKS | Flex Pharma, Inc. | KOZIN MARC D | Director | Buy | P | 11.38 | 4,500 | 51,219 | 4,500 | 0 to 4.5 K |
Oct 06 2015 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Buy | P | 10.79 | 4,800 | 51,792 | 20,553 | 15.8 K to 20.6 K (+30.47 %) |
Oct 02 2015 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 0.00 | 1,141 | 0 | 15,753 | 14.6 K to 15.8 K (+7.81 %) |
Sep 10 2015 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Buy | P | 17.60 | 3,000 | 52,800 | 14,612 | 11.6 K to 14.6 K (+25.84 %) |
Jul 02 2015 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 28.93 | 334 | 9,663 | 11,612 | 11.3 K to 11.6 K (+2.96 %) |
Jul 01 2015 | FLKS | Flex Pharma, Inc. | KOZIN MARC D | Director | Option Exercise | A | 17.43 | 10,000 | 174,300 | 10,000 | |
Jun 12 2015 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Option Exercise | A | 19.97 | 2,921 | 58,332 | 2,921 | |
Jun 12 2015 | UFPT | UFP TECHNOLOGIES I ... | KOZIN MARC D | Director | Grant | A | 0.00 | 876 | 0 | 5,890 | 5 K to 5.9 K (+17.47 %) |
Jun 08 2015 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Option Exercise | A | 36.19 | 12,000 | 434,280 | 12,000 | |
May 18 2015 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | A | 6.02 | 13,500 | 81,270 | 13,500 | |
May 18 2015 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
May 14 2015 | DYAX | DYAX CORP | KOZIN MARC D | Director | Option Exercise | A | 26.23 | 25,000 | 655,750 | 25,000 | |
Apr 09 2015 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Buy | P | 28.45 | 3,000 | 85,350 | 11,278 | 8.3 K to 11.3 K (+36.24 %) |
Apr 02 2015 | OVAS | OvaScience, Inc. | KOZIN MARC D | Director | Grant | A | 34.73 | 278 | 9,655 | 8,278 | 8 K to 8.3 K (+3.48 %) |
Oct 27 2004 | LYNX | Solexa, Inc. | KOZIN MARC D | Director | Option Exercise | A | 2.96 | 1,250 | 3,700 | 1,250 |
Page: 1